Back to top
more

Edwards Lifesciences (EW)

(Delayed Data from NYSE)

$68.12 USD

68.12
5,481,354

+1.62 (2.44%)

Updated Aug 15, 2024 04:00 PM ET

After-Market: $68.12 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (80 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Urmimala Biswas headshot

Medical Instruments Outlook Dull Amid Coronavirus Crisis

Many sub domains within the medical instrument space are bearing the brunt of the coronavirus-led prolonged stay-at-home orders.

Here's Why You Should Hold on to Edwards Lifesciences for Now

Investors continue to be upbeat about Edwards Lifesciences (EW) owing to its strong segmental growth and robust product demand.

Sriparna Ghosal headshot

3 Cheap MedTech Stocks Set to Gain Once Coronavirus Crisis Ebbs

Once the pandemic-led crisis eases, these MedTech stocks will likely flourish on the back of number of positive developments.

Edwards Lifesciences' SAPIEN 3 THV Cleared for Use in China

Edwards Lifesciences' (EW) SAPIEN 3 THV to be used an alternative to open-heart surgery for high and extreme-risk AS patients post approval in China.

Here's Why You Should Hold on to Edwards Lifesciences for Now

Investors continue to be optimistic about Edwards Lifesciences (EW) on robust demand for products and a promising surgical structural heart business.

Edwards Lifesciences (EW) Down 1% Since Last Earnings Report: Can It Rebound?

Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The Zacks Analyst Blog Highlights: Cisco, Abbott Laboratories, NextEra Energy, Gilead Sciences and Edwards Lifesciences

The Zacks Analyst Blog Highlights: Cisco, Abbott Laboratories, NextEra Energy, Gilead Sciences and Edwards Lifesciences

Sheraz Mian headshot

Top Stock Research Reports for Cisco, Abbott, NextEra & Others

Today's Research Daily features new research reports on 16 major stocks, including Cisco (CSCO), Abbott Laboratories (ABT) and NextEra Energy (NEE).

The Zacks Analyst Blog Highlights: Intel and Edwards Lifesciences

The Zacks Analyst Blog Highlights: Intel and Edwards Lifesciences

Edwards Lifesciences (EW) Beats on Q1 Earnings, Cuts '20 View

Amid the coronavirus impact on sales, Edwards Lifesciences (EW) witnesses growth in TAVR procedures led by strong therapy adoption across all geographies, particularly in the United States.

Mark Vickery headshot

Intel, Edwards Lifesciences Top Q1 Earnings Estimates

The chipmaker giant and the MedTech company both outperformed expectations in their Q1 earnings reports.

Edwards Lifesciences (EW) Q1 Earnings and Revenues Top Estimates

Edwards Lifesciences (EW) delivered earnings and revenue surprises of 17.05% and 7.64%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Can TAVR's SAPIEN 3 Aid Edwards Lifesciences (EW) Q1 Earnings?

Robust customer adoption of the HemoSphere all-in-one monitoring platform and TAVR treatments is likely to have driven Edwards Lifesciences' (EW) Q1 revenues.

Edwards Lifesciences (EW) Outpaces Stock Market Gains: What You Should Know

Edwards Lifesciences (EW) closed the most recent trading day at $217.52, moving +1.34% from the previous trading session.

Edwards Lifesciences (EW) Earnings Expected to Grow: Should You Buy?

Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kevin Cook headshot

Bull of the Day: Penumbra (PEN)

This $5 billion innovator removes blood clots and the deadly shadow of stroke with catheter-based aspiration technologies

Edwards Lifesciences (EW) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Edwards Lifesciences (EW) closed at $194.73, marking a -0.35% move from the previous day.

Edwards Lifesciences, The Trade Desk, Blue Apron, Domino's Pizza and Grubhub highlighted as Zacks Bull and Bear of the Day

Edwards Lifesciences, The Trade Desk, Blue Apron, Domino's Pizza and Grubhub highlighted as Zacks Bull and Bear of the Day

Zacks Value Trader Highlights: eBay, Pfizer, JPMorgan Chase, Intuitive Surgical and Edwards Lifesciences

Zacks Value Trader Highlights: eBay, Pfizer, JPMorgan Chase, Intuitive Surgical and Edwards Lifesciences

Kevin Cook headshot

Bull of the Day: Edwards Lifesciences (EW)

While most elective procedures are being deferred, the innovator of minimally-invasive heart valve replacement beats on

Tracey Ryniec headshot

5 Superstar Stocks on Sale During the Coronavirus Crisis

Stocks are the only thing people won't buy when they go on sale. But with stocks in a bear market, now's your chance to pick up some of the best companies.

Medtronic Demonstrates All-Line Growth Despite Cost Concerns

Major business lines of Medtronic (MDT) register stellar growth across all customer groups and geographies in Q3.

Here's Why You Should Buy Edwards Lifesciences Stock Now

Investor confidence is high in Edwards Lifesciences (EW) stock, courtesy of solid prospects.

Why Is Edwards Lifesciences (EW) Down 12.5% Since Last Earnings Report?

Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Edwards Lifesciences (EW) Stock Might be a Great Pick

Edwards Lifesciences (EW) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.